We found that PTEN mRNA levels do not correlate with PIK3CA mutations in ER+ breast cancer, suggesting that the contribution of decreased PTEN to activation of PI3K signaling is independent of PIK3CA mutations. The gene discussed is PTEN; the disease is breast cancer.